Findings

What do systematic reviews say?

4,783 questions · 10,022 findings · 882 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,100 · 21%GRADE not reported 1,013 · 10.1%Very low 2,237 · 22.3%Low 2,514 · 25.1%Moderate 1,709 · 17.1%High 449 · 4.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Behavioural activation vs treatment

quality of life (continuous)up to 6 months (2 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1299 participants
Very low

Behavioural activation vs treatment

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 88 participants
Low

Behavioural activation vs treatment

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1063 participants
Moderate

Behavioural activation vs treatment

adverse events(8‐10 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1471 participants
Moderate

Behavioural activation vs CBT

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 111 participants
Very low

Behavioural activation vs CBT

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 646 participants
Moderate

Behavioural activation vs CBT

adverse events (16 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 398 participants
Moderate

Behavioural activation vs third‐wave CBT

treatment efficacy up to 6 months (4‐8 weeks) · depression in adults

Behavioural activation showed no clear difference in treatment efficacy up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 1.1 [0.91, 1.33]
2 studies · 98 participants
Low

Behavioural activation vs third‐wave CBT

Secondary outcome: acceptability of treatment · depression in adults

Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 0.84 [0.33, 2.1]
3 studies · 147 participants
Low

Behavioural activation vs any comparator

Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases

Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.53 [0.98, 2.38]
2 studies · 176 participants
Low

Behavioural activation vs any comparator

Quality of life (medium term: 12 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases

2 findings from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low
Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases

2 findings from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low
Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Treatment efficacy for depression (medium term: 12 months) · depression in adults with non‐communicable diseases

Behavioural activation probably leads to higher treatment efficacy for depression (medium term: 12 months) compared with any comparator (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.76 [1.01, 3.08]
1 study · 92 participants
Moderate

Behavioural activation vs any comparator

Treatment efficacy for depression (long term: 24 months) · depression in adults with non‐communicable diseases

Behavioural activation showed no clear difference in treatment efficacy for depression (long term: 24 months) compared with any comparator (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.42 [0.91, 2.23]
1 study · 67 participants
Moderate

Behavioural activation vs any comparator

Acceptability · depression in adults with non‐communicable diseases

Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).

2 findings from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.81 [0.68, 4.82]
1 study · 80 participants
Low
Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 0.88 [0.25, 3.1]
1 study · 101 participants
Low

Behavioural activation vs any comparator

Improvement in depression symptoms (short term: 5–6 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 176 participants
Low

Behavioural activation vs any comparator

Improvement in depression symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 172 participants
Low

Behavioural activation vs any comparator

Improvement in depression symptoms (long term: 5 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 67 participants
Moderate

Behavioural activation vs any comparator

Quality of life (short term: 6 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low